Union Health Minister J P Nadda Calls for Strengthening India's Drugs Regulatory Framework

  • July 18, 2024, 12:52 a.m.

Union Health Minister Shri J P Nadda emphasized the need for India to elevate its regulatory framework for drugs, cosmetics, and medical devices to global standards, aligning with the country's reputation as the 'Pharmacy of the World'. He made these remarks during a comprehensive review meeting held today to assess the regulation practices within the Central Drugs Standard Control Organization (CDSCO) and the Union Health Ministry.

Accompanied by Union Health Secretary Shri Apurva Chandra, Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi, and senior officials from CDSCO, Minister Nadda underscored India's global position as a leading producer and exporter of pharmaceuticals. He stressed the necessity for CDSCO to devise a roadmap with clear timelines to achieve international benchmarks in its regulatory mandates.

"In order to maintain our status as the global leader in drugs regulation, our regulatory framework must match our scale of operations and international expectations," stated Minister Nadda. He highlighted the importance of system-based upscaling, emphasizing uniformity, technical advancement, and a forward-thinking approach in regulatory practices.

Minister Nadda also emphasized the critical role of transparency in CDSCO's operations and interactions with the pharmaceutical and medical devices industry. "Transparency in procedures within CDSCO and the industry is crucial for achieving global standards," he affirmed. He called for adherence to principles that ensure products manufactured and exported from India meet the highest global quality standards.

Furthermore, Minister Nadda emphasized the necessity for continuous dialogue between CDSCO and industry stakeholders to address challenges and support compliance with regulatory standards. "We must focus on developing mechanisms that facilitate ease of doing business for the drugs industry while maintaining regulatory rigor," he added.

Concluding the meeting, Minister Nadda reiterated the importance of CDSCO evolving into a user-friendly organization equipped with state-of-the-art facilities comparable to global standards. He emphasized the need for CDSCO to proactively engage with industry partners to understand their concerns and collaborate towards achieving excellence in regulatory practices.

The review meeting chaired by Minister J P Nadda signifies India's commitment to enhancing its regulatory framework in the pharmaceutical sector, aiming to uphold its global reputation as a reliable provider of high-quality drugs and medical products.

Author : Rajdhani Delhi Representative

Rajdhani delhi representative

Related News